Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Merck
Medtronic
Dow
Moodys

Last Updated: September 26, 2022

THEOLAIR-SR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Theolair-sr patents expire, and what generic alternatives are available?

Theolair-sr is a drug marketed by 3M and is included in four NDAs.

The generic ingredient in THEOLAIR-SR is theophylline. There are thirty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Theolair-sr

A generic version of THEOLAIR-SR was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Sign up for a Free Trial

US Patents and Regulatory Information for THEOLAIR-SR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 088369-001 Jul 16, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 089132-001 Jul 16, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 086363-002 Jul 16, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
3m THEOLAIR-SR theophylline TABLET, EXTENDED RELEASE;ORAL 088364-001 Jul 16, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Boehringer Ingelheim
Moodys
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.